152 lines (151 with data), 4.9 kB
T1 Age 2 13 42-year-old
T2 Sex 14 19 woman
T3 Sign_symptom 50 54 lump
E1 Sign_symptom:T3
T4 Biological_structure 37 49 right breast
R1 MODIFY Arg1:T4 Arg2:E1
T5 Sign_symptom 67 71 pain
E2 Sign_symptom:T5
T6 Biological_structure 56 66 lower back
R2 MODIFY Arg1:T6 Arg2:E2
T7 Sign_symptom 73 87 loss of height
E3 Sign_symptom:T7
T8 Sign_symptom 96 104 kyphosis
E4 Sign_symptom:T8
T9 Sign_symptom 109 121 hepatomegaly
E5 Sign_symptom:T9
T10 Diagnostic_procedure 128 136 biopsies
E6 Diagnostic_procedure:T10
T11 Biological_structure 146 157 breast lump
R3 MODIFY Arg1:T11 Arg2:E6
T12 Disease_disorder 165 181 ductal carcinoma
E7 Disease_disorder:T12
T13 Diagnostic_procedure 275 281 biopsy
E8 Diagnostic_procedure:T13
T14 Biological_structure 290 321 ipsilateral axillary lymph node
R4 MODIFY Arg1:T14 Arg2:E8
T15 Disease_disorder 349 370 ductal adenocarcinoma
E9 Disease_disorder:T15
T16 Detailed_description 338 348 metastatic
R5 MODIFY Arg1:T16 Arg2:E9
T17 Diagnostic_procedure 399 418 Computed tomography
E10 Diagnostic_procedure:T17
T18 Disease_disorder 444 462 metastatic disease
E11 Disease_disorder:T18
T19 Biological_structure 466 471 bones
R6 MODIFY Arg1:T19 Arg2:E11
T20 Biological_structure 473 479 pleura
T21 Biological_structure 484 489 liver
R7 MODIFY Arg1:T20 Arg2:E11
R8 MODIFY Arg1:T21 Arg2:E11
T22 Detailed_description 433 443 widespread
R9 MODIFY Arg1:T22 Arg2:E11
T23 Medication 581 592 trastuzumab
E12 Medication:T23
T24 Medication 597 622 taxane-based chemotherapy
E13 Medication:T24
T25 Sign_symptom 651 659 response
E14 Sign_symptom:T25
T26 Detailed_description 643 650 partial
T27 Detailed_description 631 642 significant
R10 MODIFY Arg1:T26 Arg2:E14
R11 MODIFY Arg1:T27 Arg2:E14
T28 Medication 699 711 chemotherapy
E15 Medication:T28
T29 Detailed_description 689 698 induction
R12 MODIFY Arg1:T29 Arg2:E15
T30 Medication 735 744 tamoxifen
E16 Medication:T30
T31 Medication 749 760 trastuzumab
E17 Medication:T31
T32 Duration 768 777 19 months
E18 Duration:T32
T33 Sign_symptom 811 819 seizures
E19 Sign_symptom:T33
T34 Diagnostic_procedure 829 848 computed tomography
E20 Diagnostic_procedure:T34
T35 Biological_structure 824 828 head
R13 MODIFY Arg1:T35 Arg2:E20
T36 Sign_symptom 866 876 metastasis
E21 Sign_symptom:T36
T37 Biological_structure 884 901 left frontal lobe
R14 MODIFY Arg1:T37 Arg2:E21
T38 Therapeutic_procedure 935 943 resected
E22 Therapeutic_procedure:T38
T39 Medication 965 974 tamoxifen
E23 Medication:T39
T40 Medication 979 990 trastuzumab
E24 Medication:T40
T41 Diagnostic_procedure 1023 1037 plasma samples
E25 Diagnostic_procedure:T41
T42 Date 1069 1086 Four months after
E26 Date:T42
T43 Sign_symptom 1120 1127 lesions
E27 Sign_symptom:T43
T44 Biological_structure 1114 1119 liver
T45 Detailed_description 1104 1113 enlarging
R15 MODIFY Arg1:T44 Arg2:E27
R16 MODIFY Arg1:T45 Arg2:E27
T46 Sign_symptom 1138 1156 metastatic deposit
E28 Sign_symptom:T46
T47 Biological_structure 1164 1174 left ovary
R17 MODIFY Arg1:T47 Arg2:E28
T48 Medication 1241 1250 lapatinib
E29 Medication:T48
T49 Medication 1255 1267 capecitabine
E30 Medication:T49
T50 Sign_symptom 1282 1296 stable disease
E31 Sign_symptom:T50
T51 Duration 1301 1310 12 months
E32 Duration:T51
T52 Sign_symptom 1334 1355 General deterioration
E33 Sign_symptom:T52
T53 Sign_symptom 1376 1395 disease progression
E34 Sign_symptom:T53
T54 Biological_structure 1403 1408 chest
R18 MODIFY Arg1:T54 Arg2:E34
T55 Disease_disorder 1443 1460 pleural effusions
E35 Disease_disorder:T55
T56 Detailed_description 1433 1442 bilateral
R19 MODIFY Arg1:T56 Arg2:E35
T57 Sign_symptom 1424 1431 nodules
E36 Sign_symptom:T57
T58 Biological_structure 1414 1423 pulmonary
R20 MODIFY Arg1:T58 Arg2:E36
T59 Sign_symptom 1486 1490 mass
E37 Sign_symptom:T59
T60 Biological_structure 1465 1485 posterior chest wall
R21 MODIFY Arg1:T60 Arg2:E37
T61 Outcome 1611 1615 died
E38 Outcome:T61
T62 Therapeutic_procedure 1573 1582 Treatment
E39 Therapeutic_procedure:T62
A1 POLARITY E39 NEG
T63 Date 1617 1631 4 months later
E40 Date:T63
T64 Clinical_event 20 29 presented
E41 Clinical_event:T64
* OVERLAP E41 E1 E2 E3 E4 E5 E6 E7 E8 E9 E10 E11
R22 BEFORE Arg1:E11 Arg2:E12
* OVERLAP E12 E13 E14 E15
R23 BEFORE Arg1:E15 Arg2:E16
* OVERLAP E16 E17 E18
R24 BEFORE Arg1:E18 Arg2:E19
* OVERLAP E19 E20 E21 E22
R25 BEFORE Arg1:E22 Arg2:E23
* OVERLAP E23 E24 E25
R26 BEFORE Arg1:E25 Arg2:E26
* OVERLAP E26 E27 E28
R27 BEFORE Arg1:E28 Arg2:E29
* OVERLAP E29 E30
R28 BEFORE Arg1:E30 Arg2:E31
* OVERLAP E31 E32
R29 BEFORE Arg1:E32 Arg2:E33
* OVERLAP E33 E34 E36 E35 E37 E42
T65 Diagnostic_procedure 1513 1566 Eastern Cooperative Oncology Group performance status
E42 Diagnostic_procedure:T65
T66 Lab_value 1567 1570 2–3
R30 MODIFY Arg1:T66 Arg2:E42
R31 BEFORE Arg1:E42 Arg2:E39
R32 BEFORE Arg1:E39 Arg2:E38
* OVERLAP E38 E40